These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24040908)

  • 21. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 22. Future of chronic obstructive pulmonary disease management.
    D'Urzo A; Vogelmeier C
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New bronchodilators.
    Mak G; Hanania NA
    Curr Opin Pharmacol; 2012 Jun; 12(3):238-45. PubMed ID: 22445544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation in COPD: implications for management.
    Sethi S; Mahler DA; Marcus P; Owen CA; Yawn B; Rennard S
    Am J Med; 2012 Dec; 125(12):1162-70. PubMed ID: 23164484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD.
    Jacobsen JR; Choi SK; Combs J; Fournier EJ; Klein U; Pfeiffer JW; Thomas GR; Yu C; Moran EJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1213-8. PubMed ID: 22178551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choice of bronchodilator therapy for patients with COPD.
    Wedzicha JA
    N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773
    [No Abstract]   [Full Text] [Related]  

  • 28. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
    Hughes AD; Jones LH
    Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
    Ray NC; Alcaraz L
    Expert Opin Ther Pat; 2009 Jan; 19(1):1-12. PubMed ID: 19441894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
    Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K
    Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
    Yıldırım N
    Tuberk Toraks; 2010; 58(2):192-201. PubMed ID: 20865575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of combining inhaled drugs for COPD.
    Bjerg A; Lundbäck B; Lötvall J
    Curr Opin Pharmacol; 2012 Jun; 12(3):252-5. PubMed ID: 22465638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis.
    Penning-van Beest F; van Herk-Sukel M; Gale R; Lammers JW; Herings R
    Respir Med; 2011 Feb; 105(2):259-65. PubMed ID: 20705441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The COPD pipeline XXII.
    Gross NJ
    COPD; 2013 Jun; 10(3):390-2. PubMed ID: 23713599
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical Approach to the Therapy of Asthma-COPD Overlap.
    Maselli DJ; Hardin M; Christenson SA; Hanania NA; Hersh CP; Adams SG; Anzueto A; Peters JI; Han MK; Martinez FJ
    Chest; 2019 Jan; 155(1):168-177. PubMed ID: 30077690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD.
    Jones LH; Baldock H; Bunnage ME; Burrows J; Clarke N; Coghlan M; Entwistle D; Fairman D; Feeder N; Fulton C; Hilton L; James K; Jones RM; Kenyon AS; Marshall S; Newman SD; Osborne R; Patel S; Selby MD; Stuart EF; Trevethick MA; Wright KN; Price DA
    Bioorg Med Chem Lett; 2011 May; 21(9):2759-63. PubMed ID: 21075627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indacterol (Arcapta Neohaler) for COPD.
    Med Lett Drugs Ther; 2012 Apr; 54(1389):33-5. PubMed ID: 22538621
    [No Abstract]   [Full Text] [Related]  

  • 38. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [COPD and diabetes mellitus. Does pulmonary medication modify blood glucose metabolism?].
    MMW Fortschr Med; 2011 Mar; 153(11):17. PubMed ID: 22165624
    [No Abstract]   [Full Text] [Related]  

  • 40. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
    Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.